Source: International Congress 2016 – Best abstracts in COPD management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Khadija Ayed (Ariana, Tunisia), Khadija Ayed, Hamida Kwas, Ines Zendah, Amel Khattab, Saloua Ben Khamsa, Habib Ghedira. Are there any differences between Tunisian and European COPD phenotypes?. Eur Respir J 2016; 48: Suppl. 60, 730

Member's Comments

No comment yet.

Related content which might interest you: GOLD and phenotypes: The new Czech COPD guidelines Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Clinical and inflammatory characteristics of 'unreported' COPD exacerbations Source: Annual Congress 2013 –COPD mechanisms Year: 2013 COPD: GOLD 2011 and implications for clinical practice Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Gender differences in COPD patients Source: International Congress 2014 – Clinical presentations Year: 2014 Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Evolution of COPD phenotypes in time - Czech multicentre research database of severe COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia Source: International Congress 2014 – COPD exacerbations Year: 2014 Symptom profile of exacerbations in earlier and later COPD Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 LATE-BREAKING ABSTRACT: Stratification of patients with COPD by frequence of exacerbations is an essential step for what to treat in COPD. - A survey in a real life COPD population Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 The distribution of phenotypes in a population of severe COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Clustering asthma and COPD provides new evidence for both “British” and “Dutch” hypotheses of COPD development Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 What is the best biomarker of COPD stability? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Outcomes of COPD exacerbations - a report from the ERS COPD audit in Austria Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 Outcomes in patients with COPD during a 3 year follow-up Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 CAT in COPD phenotypes (POPE study) Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Three year follow-up of distribution and stability of patients with COPD according GOLD 2014 Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Is an EXACT score applicable Japanese patients with COPD? Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education Year: 2013 Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS) Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016